NBD AI Bulletin -- Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SH 603392, close price: 150.44 yuan) on November 25 announced that Li Shayan hadn't offload any share in Company during the period of stock reduction plan.

In 2021, the operating revenue of the Company was made up of vaccines (58.48%) and in vitro diagnoses (40.68%).

Beijing Wantai Biological Pharmacy Enterprise's chairman and general manager is Qiu Zixin, male, 59 years old, undergraduate.

As of press time, the market value of Beijing Wantai Biological Pharmacy Enterprise was 136.3 billion yuan.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.